Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Incidence and Mortality of Lung Cancer and Their Relationship to Development in Asia Publisher



Pakzad R1 ; Mohammadianhafshejani A2 ; Ghoncheh M3 ; Pakzad I4 ; Salehiniya H1, 5, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
  4. 4. Department of Microbiology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran
  5. 5. Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Students' Scientific Research Center, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Translational Lung Cancer Research Published:2015


Abstract

Background: Lung cancer is the deadliest cancer worldwide and the most common cancer in Asia. It is necessary to get information on epidemiology and inequalities related to incidence and mortality of the cancer to use for planning and further research. This study aimed to investigate epidemiology and inequality of incidence and mortality from lung cancer in Asia. Methods: The study was conducted based on data from the world data of cancer and the World Bank [including the Human Development Index (HDI) and its components]. The incidence and mortality rates, and cancer distribution maps were drawn for Asian countries. To analyze data, correlation test between incidence and death rates, and HDI and its components at significant was used in the significant level of 0.05 using SPSS software. Results: A total of 1,033,881 incidence (71.13% were males and 28.87% were females. Sex ratio was 2.46) and 936,051 death (71.45% in men and 28.55% in women. The sex ratio was 2.50) recorded in Asian countries in 2012. Five countries with the highest standardized incidence and mortality rates of lung cancer were Democratic Republic of Korea, China, Armenia, Turkey, and Timor-Leste, respectively. Correlation between HDI and standardized incidence rate was 0.345 (P=0.019), in men 0.301 (P=0.042) and in women 0.3 (P=0.043); also between HDI and standardized mortality rate 0.289 (P=0.052), in men 0.265 (P=0.075) and in women 0.200 (P=0.182). Conclusions: The incidence of lung cancer has been increasing in Asia. It is high in men. Along with development, the incidence and mortality from lung cancer increases. It seems necessary to study reasons and factors of increasing the incidence and mortality of lung cancer in Asian countries. © Translational lung cancer research.
Related Docs
View other Related Docs
1. Relation Between Lung Cancer Incidence and Mortality Rates With Human Development Index and Its Components: A Global Ecological Study, International Journal of Cancer Management (2016)
2. Incidence and Mortality of Prostate Cancer and Their Relationship With the Human Development Index Worldwide, Prostate International (2016)
3. Incidence and Mortality of Bladder Cancer and Their Relationship With Development in Asia, Asian Pacific Journal of Cancer Prevention (2015)
4. Incidence and Mortality of Kidney Cancer and Its Relationship With Hdi (Human Development Index) in the World in 2012, Clujul Medical (2017)
5. The Incidence and Mortality of Esophageal Cancer and Their Relationship to Development in Asia, Annals of Translational Medicine (2016)
6. Incidence and Mortality of Colorectal Cancer and Relationships With the Human Development Index Across the World, Asian Pacific Journal of Cancer Prevention (2016)
7. Epidemiology, Incidence, and Mortality of Gallbladder Cancer and Its Relation With Development in the World, Annals of Tropical Medicine and Public Health (2017)
8. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
Experts (# of related papers)
Nima Rezaei (1)
Azin Nahvijou (1)
Other Related Docs
9. The Incidence and Mortality of Prostate Cancer and Its Relationship With Development in Asia, Prostate International (2015)
10. Epidemiology, Incidence and Mortality of Bladder Cancer and Their Relationship With the Development Index in the World, Asian Pacific Journal of Cancer Prevention (2016)
11. Incidence of Primary Breast Cancer in Iran: Ten-Year National Cancer Registry Data Report, Cancer Epidemiology (2015)
12. Lack of Any Relationship of Stomach Cancer Incidence and Mortality With Development in Asia, Asian Pacific Journal of Cancer Prevention (2016)
13. Global Inequality in the Incidence and Mortality Rates of Esophageal Cancer: A Country-Level Analysis, International Journal of Cancer Management (2018)
14. Disability-Adjusted Life Years (Daly) for Cancers in Iran, 1990 to 2016: Review of Findings From the Global Burden of Disease Study, Iranian Journal of Public Health (2021)
15. Epidemiology, Incidence and Mortality of Lung Cancer and Their Relationship With the Development Index in the World, Journal of Thoracic Disease (2016)